Company / Operating Margin
Mirum Pharmaceuticals, Inc. Operating Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-4.3%
FY2025
5-year range
-906.1% / -4.3%
FY2022-FY2025
Trend
+83.7%
vs FY2024
Sector context
#56 of 135
Health Care
What the data says
At -4.3%, Mirum Pharmaceuticals, Inc.'s operating margin ranks #56 of 135 in the Health Care sector. Operating Margin has increased for 3 consecutive years, from -906.1% in FY2022 to -4.3% in FY2025.
Based on SEC 10-K filings.
-4.3% in FY2025 with a 3-year CAGR of +901.9%.
Improved from -58.6% to -4.3% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +901.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#56 of 135 in Health CareTop 41% of 135This company -4.3% Sector average -774.4%
▼
+99.5% above sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 83.7% year-over-year.
- Currently 770.2pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.3% | +83.7% |
| FY2024 | -26.0% | +55.6% |
| FY2023 | -58.6% | +93.5% |
| FY2022 | -906.1% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026